secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPLASH BEVERAGE GROUP, INC. (SBEV)
CIK:        0001553788
Form:       8-K
Filed at:   2026-08-20T13:06:08+00:00
Accession:  0001731122-26-001114
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Splash Beverage Q2 loss narrows 64% to ~$4M; rebranding as Endovia Health Sciences
--------------------------------------------------------------------------------

- H1 2026 loss from continuing ops ~$4M vs ~$11M in H1 2025, improvement of ~$7M (64%).
- In early July 2026, entered exclusive global license for CannEpil®, a pharma-grade cannabinoid platform for drug-resistant epilepsy.
- On Jul 31 2026, signed development agreement with Lupvindol Biosciences to advance CannEpil® veterinary product through FDA INAD and Conditional Approval.
- Rebrand to Endovia Health Sciences with name and ticker change effective on NYSE American Aug 24, 2026.
- Preparing to relaunch CannEpil® in UK, Ireland and select Latin American markets through existing distribution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226001114/0001731122-26-001114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226001114/e7875_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-001114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer